




Searching News Database: retinitis pigmentosa
HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
HSMN NewsFeed - 24 Feb 2016
Pixium Vision Implants IRIS(R) II, First Epi-Retinal Implant with 150 Electrodes
Pixium Vision Implants IRIS(R) II, First Epi-Retinal Implant with 150 Electrodes
HSMN NewsFeed - 15 Sep 2014
Retina Implant AG's International Clinical Results Presented for the First Time in Europe
Retina Implant AG's International Clinical Results Presented for the First Time in Europe
HSMN NewsFeed - 1 Oct 2012
FDA Panel Recommends FDA Approval for Second Sight’s Argus(R) II Retinal Prosthesis System
FDA Panel Recommends FDA Approval for Second Sight’s Argus(R) II Retinal Prosthesis System
HSMN NewsFeed - 21 Nov 2011
Retina Implant AG Gains Unanimous Scientific Advisory Board Approval To Expand Clinical Trial Across Europe
Retina Implant AG Gains Unanimous Scientific Advisory Board Approval To Expand Clinical Trial Across Europe
HSMN NewsFeed - 2 Mar 2011
Retina Implant AG Secures $18 Million in Second Round of Venture Capital Funding
Retina Implant AG Secures $18 Million in Second Round of Venture Capital Funding
HSMN NewsFeed - 6 Apr 2010
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
IMI Intelligent Medical Implants Names Robert J. Rosenthal Chief Executive Officer
HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
HSMN NewsFeed - 17 Apr 2007
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
HSMN NewsFeed - 25 Oct 2006
The Optobionics Pilot Clinical Study Shows Promising Vision Improvement for Retinitis Pigmentosa Patients
The Optobionics Pilot Clinical Study Shows Promising Vision Improvement for Retinitis Pigmentosa Patients
Additional items found! 22

Members Archive contains
22 additional stories matching:
retinitis pigmentosa
(Password required)
retinitis pigmentosa
(Password required)